AP 811

High affinity, selective ANP clearance receptor (NPR3) antagonist (Ki = 0.45 nM) that exhibits >20,000-fold selectivity for NPR3 over NPR1.

Online Inquiry

Specification Technical Data Related Products Customer reviews and Q&A Useful Tools Publications

CAT#	R0974
CAS	124833-45-0
Synonyms/Alias	N2-[[4-[(2-Naphthalenylcarbonyl)amino]phenyl]acetyl]-L-arginyl-L-isoleucyl-L-α-aspartyl-N-[(2S)-2-methylbutyl]-L-argininamide; (S)-N2-[[4-[(2-Naphthalenylcarbonyl)amino]phenyl]acetyl]-L-arginyl-L-isoleucyl-L-α-aspartyl-N-(2-methylbutyl)-L-argininamide; AP 811;
M.F/Formula	C46H66N12O8
M.W/Mr.	915.1
Sequence	RIDR(Modifications: Arg-1 = N2-[4-(2-Naphthoylamino)phenylacetyl], Arg-4 = C-terminal (S)-2-methylbutylamide)
Labeling Target	ANP clearance receptor (NPR3)
Activity	Antagonist

CAT#	Product Name	Inquiry
R1310	C-telopeptide	Inquiry
R1703	TAK-448	Inquiry
R1767	β-Amyloid (1-42), rat TFA	Inquiry
R1633	Prolactin Releasing Peptide (12-31), human	Inquiry
R1773	β-Amyloid 1-20	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Storage	-20°C
InChI	InChI=1S/C46H66N12O8/c1-5-27(3)26-53-34(13-9-21-51-45(47)48)41(63)58-43(65)36(25-38(60)61)56-44(66)39(28(4)6-2)57-42(64)35(14-10-22-52-46(49)50)55-37(59)23-29-15-19-33(20-16-29)54-40(62)32-18-17-30-11-7-8-12-31(30)24-32/h7-8,11-12,15-20,24,27-28,34-36,39,53H,5-6,9-10,13-14,21-23,25-26H2,1-4H3,(H,54,62)(H,55,59)(H,56,66)(H,57,64)(H,60,61)(H4,47,48,51)(H4,49,50,52)(H,58,63,65)/t27-,28-,34-,35-,36-,39-/m0/s1
InChI Key	CWKUICQDCFQXIS-OCFLPWLCSA-N
Isomeric SMILES	CC[C@H](C)CN[C@@H](CCCN=C(N)N)C(=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2
BoilingPoint	N/A
Melting Point	N/A